Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Borogluconate
2. Borogluconate, Calcium Salt
3. Calcium Borogluconate
1. Borogluconate
2. 87-46-7
3. X8p2sy4y7v
4. (2r,3r)-2,3-dihydroxy-3-((4s,5r)-2-hydroxy-5-(hydroxymethyl)-1,3,2-dioxaborolan-4-yl)propanoic Acid
5. Unii-x8p2sy4y7v
6. Starbld0036467
7. Boricum Gluconicum
8. Borogluconate [who-dd]
9. D-gluconic Acid, Cyclic 4,5-ester With Boric Acid (h3bo3)
10. Dtxsid001018983
11. 4-o,5-o-(hydroxyboranediyl)-d-gluconic Acid
12. Q27293687
| Molecular Weight | 221.96 g/mol |
|---|---|
| Molecular Formula | C6H11BO8 |
| Hydrogen Bond Donor Count | 5 |
| Hydrogen Bond Acceptor Count | 8 |
| Rotatable Bond Count | 4 |
| Exact Mass | 222.0546975 g/mol |
| Monoisotopic Mass | 222.0546975 g/mol |
| Topological Polar Surface Area | 137 Ų |
| Heavy Atom Count | 15 |
| Formal Charge | 0 |
| Complexity | 235 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 4 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
A X8P2SY4Y7V manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of X8P2SY4Y7V, including repackagers and relabelers. The FDA regulates X8P2SY4Y7V manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. X8P2SY4Y7V API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A X8P2SY4Y7V supplier is an individual or a company that provides X8P2SY4Y7V active pharmaceutical ingredient (API) or X8P2SY4Y7V finished formulations upon request. The X8P2SY4Y7V suppliers may include X8P2SY4Y7V API manufacturers, exporters, distributors and traders.
X8P2SY4Y7V Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of X8P2SY4Y7V GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right X8P2SY4Y7V GMP manufacturer or X8P2SY4Y7V GMP API supplier for your needs.
A X8P2SY4Y7V CoA (Certificate of Analysis) is a formal document that attests to X8P2SY4Y7V's compliance with X8P2SY4Y7V specifications and serves as a tool for batch-level quality control.
X8P2SY4Y7V CoA mostly includes findings from lab analyses of a specific batch. For each X8P2SY4Y7V CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
X8P2SY4Y7V may be tested according to a variety of international standards, such as European Pharmacopoeia (X8P2SY4Y7V EP), X8P2SY4Y7V JP (Japanese Pharmacopeia) and the US Pharmacopoeia (X8P2SY4Y7V USP).
LOOKING FOR A SUPPLIER?
